Orion Biotech Opportunities Overview
Valuation check: ORIA's PEG ratio is -1.58, below the sector sector average of 6.34.
Get informed when a big investor buys or sells
+ Follow-1.58
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Orion Biotech Opportunities (ORIA) currently reports a PEG ratio of -1.58. That is below the sector sector average of 6.34. Use the charts on this page to explore Orion Biotech Opportunities's PEG ratio history and peer comparisons.
Orion Biotech Opportunities's PEG ratio of -1.58 is lower than the its sector sector average of 6.34. That is roughly 125.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Orion Biotech Opportunities's market price to a fundamental measure such as earnings, sales, or book value. At -1.58, ORIA can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -1.58, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 6.34. From there, open related valuation or income-statement pages for Orion Biotech Opportunities, and consider following ORIA for alerts when major investors trade the stock.
